Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ISTURISA® safely and effectively. See full prescribing information for ISTURISA. ISTURISA (osilodrostat) tablets, for oral use Initial U.S. Approval: 2020
Medication labelWhy this: Advisory · dailymed-prescription
ISTURISA is indicated for the treatment of endogenous hypercortisolemia in adults with Cushing's syndrome for whom surgery is not an option or has not been curative.
- generic_name
- osilodrostat
- product_names
- Osilodrostat, osilodrostat, OSILODROSTAT
- ndc
- 55292-330, 55292-330-60, 55292-330-20, 55292-331, 55292-331-60, 55292-331-20, 55292-320, 55292-320-60, 55292-320-20, 55292-321, 55292-321-60, 55292-321-20, 55292-322, 55292-322-60, 55292-322-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en